Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Dec;23(4):254-9.
doi: 10.1007/s12022-012-9219-6.

Villous papillary thyroid carcinoma: a variant associated with marfan syndrome

Affiliations
Case Reports

Villous papillary thyroid carcinoma: a variant associated with marfan syndrome

Daniel A Winer et al. Endocr Pathol. 2012 Dec.

Abstract

Marfan syndrome (MFS) is an autosomal dominant hereditary disorder of connective tissue associated with perturbations in transforming growth factor β (TGF-β) biology, most often due to mutations in FBN1 gene that encodes fibrillin-1. To our knowledge, there is no known association of MFS with thyroid carcinoma. We report a 46-year-old man with known history of MFS who developed an unusual histological variant of papillary thyroid carcinoma. The tumor exhibited a widely invasive florid papillary growth pattern with prominent long villous fronds. Immunohistochemical and molecular analysis revealed a BRAF(V600E) mutation, evidence of aggressive biomarker expression (positivity for HBME-1, cytokeratin 19, galectin-3 and cyclin D1, and loss of p27), and changes associated with TGF-β-related epithelial-to-mesenchymal transition with active phospho-SMAD signaling. We introduce a unique histological pattern of papillary thyroid carcinoma that is associated with MFS. The combination of BRAF(V600E) mutation in the setting of altered TGF-β signaling and weak connective tissue integrity associated with MFS may cooperate and possibly be responsible to form this unique villous morphology with epithelial-to-mesenchymal transition and invasive growth.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2803-8 - PubMed
    1. Nat Rev Cancer. 2010 Jun;10(6):415-24 - PubMed
    1. Proc Natl Acad Sci U S A. 2007 May 22;104(21):9001-6 - PubMed
    1. Mod Pathol. 2011 Dec;24(12):1545-52 - PubMed
    1. J Indian Med Assoc. 1963 Jan 1;40:23-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources